Quotables
"Man will not fly for 50 years."
Wilbur Wright ; 1901
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7429658 | Synthesis of protected pyrrolobenzodiazepines A method of synthesis of a N-10 protected PBD compound of formula (I): via an intermediate of formula (II) or formula (V): ... | 09/30/2008 |
| 7414145 | Method of enantioselective nucleophilic addition reaction of enamide to carbonyl group and synthesis method of optically active α-hydroxy-γ-keto acid ester and hydroxydiketone A method of an enantioselective nucleophilic addition reaction to carbonyl, which enables an asymmetric synthesis of an optically active α-hydroxy-γ-keto acid ester, an optically active α-hydroxy-γ-amino acid ester, hydroxydiketone compounds, etc. being useful a... | 08/19/2008 |
| 7410965 | Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol A delayed release pharmaceutical formulation containing 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol or a pharmaceutically acceptable salt thereof in a matrix; said matrix containing from 1 to 80 wt. % of at least one pharmaceutically acceptable, matrix-f... | 08/12/2008 |
| 7312245 | Diamine derivatives, process for producing the diamine derivatives, and fungicides containing the diamine derivatives as an active ingredient A fungicide can be provided by using, as an active ingredient, a diamine derivative of the following general formula (1): wherein R1 to R7 represent a specific substituen... | 12/25/2007 |
| 7253318 | Benzyloxy derivatives as MAOB inhibitors The invention relates to compounds of the formula and their pharmaceutically acceptable salts wherein R1, R2, R3, R4, R5, n, m, and o are... | 08/07/2007 |
| 7226991 | Phenylalanine derivatives Disclosed herein are phenylalanine derivative compounds of the following formula W—Y—(AA)n—Z wherein Y is a phenylalanyl radical, AA is an amino acid, n is an integer of 1 to 15, and substituent variables W and Z are as described... | 06/05/2007 |
| RE39616 | Aminoindan derivatives This invention is directed to compounds of the following formula: wherein when a is 0, b is 1 or 2; when a is 1, b is 1, m is from 0-3, X is O or S, Y is halogeno, R1 is hydrogen C1-4 alkyl, R2 is... | 05/08/2007 |
| RE39593 | 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects 1-phenyl-3-dimethylaminopropane compounds corresponding to the formula I a method of preparing them, and the use of these substances as analgesic active ingredients in pharmaceutical compositions. ... | 04/24/2007 |
| 7084189 | Phase change inks with isocyanate-derived antioxidants and UV stabilizers Disclosed is a phase change ink composition comprising (a) a colorant and (b) the reaction product of (i) an isocyanate and (ii) an antioxidant or UV stabilizer molecule having thereon (A) at least one isocyanate-reactive hydroxyl group and/or (B) at least one isocy... | 08/01/2006 |
| 7041863 | Zeolite Y alkylation catalysts The present invention is directed to a zeolite Y catalyst having a controlled macropore structure. The present invention is also directed to a zeolite Y catalyst composite and a process for preparing the catalyst composite. The catalyst composite exhibits reduced de... | 05/09/2006 |
| 7026515 | Optically active amine derivatives and preparation process therefor A readily available and inexpensive natural α-amino acid is converted into a compound represented by formula (1), which is then reacted with an organometallic reagent represented by formula (2) to give an optically active 5-hydroxyoxazolidine represented by formula... | 04/11/2006 |
| 6972292 | Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors The present invention relates to certain substituted polyketides of formula I, wherein A, B, C, D, E, F and m are as defined herein, pharmaceutical compositions containing said compounds, and the use of said compounds ... | 12/06/2005 |
| 6852738 | Acyl sulfamides for treatment of obesity, diabetes and lipid disorders A class of acyl sulfamides comprises compounds that are potent ligands for PPAR gamma and generally have antagonist or partial agonist activity. The compounds may be useful in the treatment, control or prevention of obesity, non-insulin dependent diabetes mellitus (... | 02/08/2005 |
| 6809207 | Amino acid derivatives The present invention provides certain alpha-amino acids and derivatives thereof, such as, but not limited to, esters, amides and salts. These derivatives may comprise such representative side groups as a phenyl, pyridyl, piperidinyl, tetrahydropyranyl, tetrahydroth... | 10/26/2004 |
| 6803383 | Inhibition of angiogenesis and tumor growth Compounds which inhibit tumor growth and angiogenesis, of general formula (II) are provided. These compounds include glycyl lysine derivatives bound to a central aromatic linking core. ... | 10/12/2004 |
| 6803378 | HIV integrase inhibitors Novel diketoacid compounds of Formula I are provided which are useful as HIV integrase inhibitors and for the treatment of AIDS or ARC. ... | 10/12/2004 |
| 6759511 | Compound used as an amino-protecting group, process for preparing the same, and synthetic method of a peptide using the same The present invention relates to a carbonic acid ester compound of the following formula (1): in which X, Y, and Ar are defined in the specification, which can be easily combined with the amino group of an amino acid or ... | 07/06/2004 |
| 6727098 | Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration A novel achiral biaryl-type compound and a circular dichroism (CD) color fixing agent are provided. Furthermore, a method for determining an absolute configuration of a chiral compound is carried out by introducing the above achiral biaryl-type compound into the chi... | 04/27/2004 |
| 6642406 | Synthesis of N-[N-(3,3-dimethylbutyl)-L--aspartyl]-L-phenylalanine 1-methyl ester using L--aspartyl-L-phenylalanine 1-methyl ester precursors N-[N-(3,3-dimethylbutyl)-L--aspartyl]-L-phenylalanine 1-methyl ester is produced by hydrogenation of a mixture of 3,3-dimethylbutyraldehyde and a precursor of L--aspartyl-L-phenylalanine 1-methyl ester. In particular, N-[N-(3,3-dimethylbutyl... | 11/04/2003 |
| 6635621 | Cysteine protease inhibitors This invention relates to derivatives of alpha-amino acid amides, to pharmaceutical compositions containing such compounds, and to their use in medicine as inhibitors of cysteine proteases, particularly the cathepsins. A compound of formula (I) is describ... | 10/21/2003 |
| 6620961 | Biarylalkylenecarbamic acid derivatives and bacteriocides for agricultural and horticultural use Biarylalkylenecarbamic acid derivative represented by general formula (I): ##STR1## [wherein Q is a phenyl group which may be substituted or the like, X is a halogen atom, a (C1 -C6) alkyl group or the like, n is 0 or an integer of f... | 09/16/2003 |
| 6541653 | Synthesis of carbamate through low pressure heterogeneous oxidative carbonylation of amines The process disclosed herein satisfies the need in the art for an industrially viable oxidative carbonylation catalytic system, and is capable of producing carbamates at a significantly higher rate than those processes reported in journal and patent liter... | 04/01/2003 |
| 6528678 | Phosgene-free process for preparing carbamates A phosgene-free method for preparing a carbamate from a compound containing an amine group involves reacting the compound with an alkylating agent in the presence of carbon dioxide and cesium carbonate. A reaction can take place under standard pressure an... | 03/04/2003 |
| 6486342 | Substituted chiral allosteric hemoglobin modifiers A family of substituted chiral allosteric effectors of hemoglobin is useful for delivering more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood.... | 11/26/2002 |
| 6455585 | Esters derived from substituted phennyl-cyclohexyl compounds New esters derived from substituted phenyl-cyclohexyl compounds, which are derived from Tramadol, process for obtaining them and their use for preparing a drug with analgesic properties. These new compounds of general formula (I) have a higher analgesic a... | 09/24/2002 |
| 6416686 | Polyisocyanates Polyisocyanates are prepared by a process which comprises (i) preparation of an addition product (A) which contains one group which is reactive toward isocyanate and one isocyanate group by reacting (a) a diisocyanate I with (b) compounds containing two groups whic... | 07/09/2002 |
| 6414158 | 1,3,4-oxadiazine derivatives and their use as pesticides The invention relates to novel carbazate intermediates of formula (II), and to a process for their preparation, and their usefulness in the preparation of (1,3,4) oxadiazine derivatives useful as pesticides, in particular as anthelminthicides, insecticide... | 07/02/2002 |
| 6350305 | Selected polymeric furanone magenta colorants A polymeric furanone magenta colorant is disclosed that contains a furanone magenta chromophore having a furanone adduct, the adduct containing at least one alkoxylated phenyl radical, the chromophore further being derived from at least one aromatic aldeh... | 02/26/2002 |
| 6344558 | 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effect 1-phenyl-3-dimethylaminopropane compounds corresponding to the formula I ##STR1## a method of preparing them, and the use of these substances as analgesic active ingredients in pharmaceutical compositions.... | 02/05/2002 |
| 6335459 | Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators This invention relates to compounds which are generally IP receptor modulators, particularly IP receptor agonists, and which are represented by Formula I: ##STR1## wherein R1, R2, R3, R4, R5, A, and B... | 01/01/2002 |
| 6306873 | Substituted ଲ-thiocarboxylic acids This invention relates to compounds of general formula (I): ##STR1## in which Ar is a group selected from: ##STR2## A1, A2, B, C, D, E, Q1-Q3, R1-R9, Z1 and Z2 are as defined in the disclosure, and Y represents carboxy or an acid bioisostere. These c... | 10/23/2001 |
| 6303650 | Aminoindan derivatives This invention is directed to compounds of the following formula ##STR1## wherein when a is O, b is 1 or 2; when a is 1, b is 1, m is from 0-3 X is O or S, Y is halogeno, R1 is hydrogen C1-4 alkyl, R2 is hydrogen, C1-... | 10/16/2001 |
| 6248737 | 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects 1-phenyl-3 -dimethylaminopropane compounds corresponding to the formula I ##STR1## a method of preparing them, and the use of these substances as analgesic active ingredients in pharmaceutical compositions.... | 06/19/2001 |
| 6235929 | Tripeptide -ketoamides A novel class of tripeptide -ketoamides useful for selectively inhibiting serine proteases, selectively inhibiting cysteine proteases, generally inhibiting all serine proteases, and generally inhibiting all cysteine proteases, having the formula M | 05/22/2001 |
| 6194458 | Benzamide potassium channel inhibitors This invention relates to benzamide potassium channel inhibitors of general structural Formula I. ##STR1## The compounds of this invention are useful in the treatment of autoimmune diseases, the prevention of rejection of foreign organ transplants and ... | 02/27/2001 |
| 6180374 | Method for preparing tert-leucine and analogues thereof in enantiomeric form and intermediates therein Azlactone (3), or the opposite enantiomer thereof, undergoes biotransformation, using suitable enzymatic activity, in the presence of a compound YH to form a N-acyl-amino acid (2), wherein R1, R2 and R3 are each not hydrog... | 01/30/2001 |
| 6174885 | [6-(substituted-methyl)-3-cyclohexenyl] formamide derivative, hair growth promoter and external composition for skin A [6-(substituted-methyl)-3-cyclohexenyl]formamide derivative or a salt thereof expressed by the following Formula (I): ##STR1## wherein one of A and B is a hydrocarbon group of C10-30 expressed by R1 and the other is--(CH2 | 01/16/2001 |
| 6172108 | Hydrazide compounds Compounds of formula (I): R--NH--A--CO--NH--NH--(W)n --Z (I) wherein: n is 0 or 1, W represents --CO-- or S(O)r wherein r is 0, 1 or 2, Z represents a group selected from aryl, arylalkyl, heteroaryl and heteroarylalkyl, each optionally substi... | 01/09/2001 |
| 6169206 | 4-(n,n-dialkylamino)aniline compound, photographic processing composition containing the same and color image-forming method 4-(N,N-Dialkylamino)aniline compounds of the following general formula (I): ##STR1## wherein R1 represents an alkyl group, an aryl group or a heterocyclic group, R2 to R5 each represent a hydrogen atom or a substituent, an... | 01/02/2001 |
| 6143917 | Process for producing aryl carbamates A process for producing an aryl carbamate of a high purity at a high yield by reacting a diaryl carbonate with an amine compound having one or more hydrogen atoms bonded to the N position in the presence of carboxylic acid(s) of the following general form... | 11/07/2000 |
